http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102697720-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e328f3403a32b1dbb56db1d343f262f5
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
filingDate 2012-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5162cebd8e673a9e453a73eb340a9deb
publicationDate 2014-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102697720-B
titleOfInvention Irinotecan hydrochloride lipid nanoparticles injection
abstract The invention discloses an irinotecan hydrochloride lipid nanoparticles injection and a preparation method thereof. Mixed phase is formed by dissolving irinotecan hydrochloride and stearic acid in organic solvent and dissolving lecithin in buffer salt solution; aqueous solution of PEG (polyethylene glycol) 400, glycerol and trehalose is adopted as aqueous phase; and then irinotecan hydrochloride is loaded in lipid nanoparticles by combining stirring emulsification and high-pressure emulsion homogenizing to obtain the irinotecan hydrochloride lipid nanoparticles injection. The inventive lipid nanoparticles preparation has the advantages of high drug loading rate, uniform particle size, long drug retention time in blood circulation, better sustained-release and controlled-release effect, simple preparation method and device, easy operation, improved product quality, reduced toxic and side effects, and suitability for industrialized production.
priorityDate 2012-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426484532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409704282
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21864422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448297742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419576306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414867404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID186148
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62551
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518326
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449203526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412667134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10925912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409164413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74990
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID16922
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10889
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78607
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414664123
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9230
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7427
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID16922

Total number of triples: 49.